Recent advances in CRISPR technologies for biomedical applications and disease treatment
Theranostics · 2026
DOI: 10.7150/thno.136062 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, 2026. Verfasst von Xue Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Genetic Therapy, Clustered Regularly Interspaced Short Palindromic Repeats. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Otolaryngology-Head &Neck Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China.
Zitieren
APA
Wu, X., Kou, X., Bai, L., Liu, C., Wu, Q., Zhang, M., Wang, N., & Gong, C. (2026). Recent advances in CRISPR technologies for biomedical applications and disease treatment. Theranostics. https://doi.org/10.7150/thno.136062
Vancouver
Wu X, Kou X, Bai L, Liu C, Wu Q, Zhang M, et al. Recent advances in CRISPR technologies for biomedical applications and disease treatment. Theranostics. 2026. doi:10.7150/thno.136062
BibTeX
@article{Wu2026,
author = {Wu, Xue and Kou, Xiaorong and Bai, Liping and Liu, Chao and Wu, Qinjie and Zhang, Ming and Wang, Ning and Gong, Changyang},
title = {Recent advances in CRISPR technologies for biomedical applications and disease treatment},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.136062}
}
EUVIMED